IAVI and Biofabri/Zendal Announce First Vaccinations in the IMAGINE Clinical Trial, a Large-scale Safety and Efficacy Trial of the Tuberculosis Vaccine Candidate MTBVAC
Tuberculosis (TB) is the world’s deadliest infectious disease, killing 1.25 million people in 2023.MTBVAC is a promising vaccine candidate being evaluated in the IMAGINE trial,